“Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer”. 2020. Archives of Clinical and Medical Case Reports 4 (6): 1108-15. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22422.